Second Patient Dosing Recommended for TSHA-102 Gene Therapy Trial in Rett Syndrome
August 2nd 2023Following a successful first patient treatment experience with TSHA-102, an adeno-associated virus vector-based gene therapy for Rett syndrome, Taysha Gene Therapies was recommended to continue with investigating the therapy in a second patient.